with Respilon Group to work on nanofiber-based drug delivery technologies, according to an exchange filing. “Sigachi Industries Limited, a leading player in pharmaceutical industry is pleased to ...

Scientists can now potentially control gel properties – like stiffness, responsiveness, or drug release rate – by targeting specific stages of the formation process revealed in this study.

Headquartered in the Czech Republic, Respilon is an innovation-driven nanofiber R&D company. Sigachi and Respilon will collaborate to develop, manufacture, and commercialize drug delivery ...

Sigachi and Respilon will collaborate to develop, manufacture, and commercialize drug delivery solutions based on Respilon's proprietary NUENEX nanofiber technology. The collaboration includes ...

There have been a growing number of drug products approved that look to target the brain following intranasal delivery.

Nanotechnology has been applied extensively in drug delivery to improve the therapeutic outcomes of various diseases. Tremendous efforts have been focused on the development of novel nanoparticles ...

Scientists have developed a method for analysing the structure of lipid nanoparticles that could be used to improve vaccine ...

that transforms the ink into a gel that can be printed into desired shapes and tailored for functions such as drug delivery and tissue replacement, according to a report published on Thursday in ...

A team led by scientists at the University of Nottingham's School of Pharmacy demonstrated a new cryogenic mass spectrometry approach for depth profiling frozen tiny lipid nanoparticles to reveal the ...

Research teams have created a versatile set of gene delivery systems that can reach different neural cell types in the human ...

Lipids have become indispensable to modern drug delivery offering a versatile toolkit for the formulation and transport of therapeutic agents. Over the past two decades, the field has experienced ...